CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
0.3123
-0.0227 (-6.78%)
At close: Jul 20, 2026, 4:00 PM EDT
0.3219
+0.0096 (3.07%)
After-hours: Jul 20, 2026, 4:12 PM EDT
CollPlant Biotechnologies Market Cap
CollPlant Biotechnologies has a market cap or net worth of $5.91 million as of July 20, 2026. Its market cap has decreased by -71.61% in one year.
Market Cap
5.91M
Enterprise Value
4.08M
1-Year Change
-71.61%
Ranking
Category
Stock Price
$0.31
ChartMarket Cap Chart
Since January 31, 2018, CollPlant Biotechnologies's market cap has decreased from $30.60M to $5.91M, a decrease of -80.70%. That is a compound annual growth rate of -17.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 4.80M | -73.18% |
| Dec 31, 2025 | 17.90M | -56.55% |
| Dec 31, 2024 | 41.20M | -43.72% |
| Dec 29, 2023 | 73.20M | -20.95% |
| Dec 30, 2022 | 92.60M | -47.06% |
| Dec 31, 2021 | 174.90M | 147.03% |
| Dec 31, 2020 | 70.80M | 226.27% |
| Dec 31, 2019 | 21.70M | 55.00% |
| Dec 31, 2018 | 14.00M | -54.25% |
| Jan 31, 2018 | 30.60M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evogene | 6.20M |
| Addex Therapeutics | 6.19M |
| BioAtla | 6.14M |
| Pulmatrix | 6.14M |
| Purple Biotech | 6.11M |
| Processa Pharmaceuticals | 6.11M |
| Cadrenal Therapeutics | 5.99M |
| Aptevo Therapeutics | 5.93M |